Skip to main content
. 2023 May 9;95(2):S79–S87. doi: 10.1097/TA.0000000000004034

TABLE 3.

In-hospital Outcomes

Missing Data (Number) Available Data (Number) Observed Data
In-hospital death 0 39 2 (5%)
Lengths of stay
ICU length of stay, median (IQR), d 0 39 6 (4–16)
Free days of ICU at day 28, median (IQR), d 0 39 22 (9–24)
Hospital length of stay in survivors, median (IQR), d 1 36 39 (14–91)
Transfusion during the stay in ICU
Transfusion of ≥1 blood product, n (%) 0 39 25 (64%)
Total no. pRBC per patient, median (IQR) 0 39 2 (0–7)
Total no. plasma units per patient, median (IQR) 0 39 0 (0–6)
Total no. platelets units per patient, median (IQR) 0 39 0 (0–1)
Infectious events during the stay in ICU
Occurrence of ≥1 infection, n (%) 0 39 17 (44%)
Respiratory infection, n (%) 0 39 11 (28%)
Urinary tract infection, n (%) 0 39 1 (3%)
Abdomen infection, n (%) 0 39 0 (−)
Cerebral infection, n (%) 0 39 0 (−)
Surgical site infection, n (%) 0 39 8 (21%)
Material infection, n (%) 0 39 0 (−)
Occurrence of ≥1 septic shock, n (%) 0 39 4 (10%)
Acquisition of MDR bacteria, n (%) 1 38 13 (34%)
Respiratory events during the stay in ICU
Mechanical ventilation for ≥1 day, n (%) 0 39 28 (72%)
Mechanical ventilation length, median (IQR), d 0 39 2 (0–8)
Free days of mechanical ventilation at day 28, median (IQR), d 0 39 26 (20–28)
Tracheostomy, n (%) 0 39 2 (5%)
Acute respiratory distress syndrome, n (%) 0 39 2 (5%)
Neurological events during the stay in ICU in TBI patients (n = 10)
Intracranial hypertension, n (%) 2 8 3 (38%)
Glasgow Coma Scale at discharge, median (IQR) 3 7 15 (14–15)

MDR, multidrug resistant.